PetIQ (PETQ) Stock Forecast, Price Target & Predictions
PETQ Stock Forecast
PetIQ stock forecast is as follows: an average price target of $31.00 (represents a 0.06% upside from PETQ’s last price of $30.98) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
PETQ Price Target
The average price target for PetIQ (PETQ) is $31.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $31.00 to $31.00. This represents a potential 0.06% upside from PETQ's last price of $30.98.
PETQ Analyst Ratings
According to 3 Wall Street analysts, PetIQ's rating consensus is 'Buy'. The analyst rating breakdown for PETQ stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
PetIQ Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 08, 2024 | Bill Chappell | Truist Financial | $31.00 | $30.42 | 1.91% | 0.06% |
The latest PetIQ stock forecast, released on Aug 08, 2024 by Bill Chappell from Truist Financial, set a price target of $31.00, which represents a 1.91% increase from the stock price at the time of the forecast ($30.42), and a 0.06% increase from PETQ last price ($30.98).
PetIQ Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $31.00 |
| Last Closing Price | $30.98 | $30.98 | $30.98 |
| Upside/Downside | -100.00% | -100.00% | 0.06% |
In the current month, the average price target of PetIQ stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to PetIQ's last price of $30.98. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 07, 2024 | William Blair | - | Market Perform | Downgrade |
| Oct 25, 2022 | Raymond James | Outperform | Outperform | Hold |
| Nov 30, 2021 | Benchmark | - | Buy | Initialise |
PetIQ's last stock rating was published by William Blair on Aug 07, 2024. The company Downgrade its PETQ rating from "null" to "Market Perform".
PetIQ Financial Forecast
PetIQ Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $219.93K | $277.02M | $314.55K | $290.47M | $184.08M | $209.72M | $252.01M | $275.69M | $196.64M | $210.53M | $271.01M | $254.35M | $164.21M | $162.08M | $266.98M | $186.78M | $154.34M | $186.03M |
| Avg Forecast | $268.41M | $328.84M | $373.30M | $343.10M | $251.43M | $309.19M | $342.10M | $320.78M | $233.38M | $289.65M | $330.14M | $300.43M | $189.04M | $229.06M | $273.77M | $277.15M | $192.48M | $204.33M | $259.40M | $269.45M | $173.35M | $196.82M | $304.60M | $210.19M | $146.08M | $166.28M | $251.50M | $176.94M | $130.28M | $173.26M |
| High Forecast | $268.41M | $328.84M | $373.30M | $343.10M | $251.43M | $309.19M | $342.10M | $320.78M | $233.38M | $290.33M | $330.14M | $300.43M | $191.83M | $229.06M | $273.77M | $277.15M | $192.48M | $204.33M | $259.40M | $269.45M | $173.35M | $196.82M | $304.60M | $210.19M | $146.08M | $166.28M | $251.50M | $176.94M | $130.28M | $173.26M |
| Low Forecast | $268.41M | $328.84M | $373.30M | $343.10M | $251.43M | $309.19M | $342.10M | $320.78M | $233.38M | $288.96M | $330.13M | $300.43M | $187.35M | $229.06M | $273.77M | $277.15M | $192.48M | $204.33M | $259.40M | $269.45M | $173.35M | $196.82M | $304.60M | $210.19M | $146.08M | $166.28M | $251.50M | $176.94M | $130.28M | $173.26M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 9 | 15 | 9 | 9 | 16 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.21% | 0.00% | 1.05% | 0.96% | 1.03% | 0.97% | 1.02% | 1.13% | 1.07% | 0.89% | 1.21% | 1.12% | 0.97% | 1.06% | 1.06% | 1.18% | 1.07% |
PetIQ's average Quarter revenue forecast for Mar 24 based on 4 analysts is $300.43M, with a low forecast of $300.43M, and a high forecast of $300.43M. PETQ's average Quarter revenue forecast represents a 136503.97% increase compared to the company's last Quarter revenue of $219.93K (Dec 23).
PetIQ EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 9 | 15 | 9 | 9 | 16 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-9.94K | $9.36M | $18.72K | $27.42M | $1.64M | $13.52M | $20.27M | $18.37M | $5.92M | $7.11M | $19.53M | $19.33M | $7.57M | $7.08M | $10.46M | $6.90M | $-4.30M | $3.50M |
| Avg Forecast | $15.56M | $19.07M | $21.65M | $19.90M | $14.58M | $17.93M | $19.84M | $18.60M | $13.53M | $16.80M | $19.14M | $16.74M | $10.96M | $13.28M | $15.88M | $15.21M | $9.57M | $11.85M | $15.04M | $13.83M | $10.05M | $11.41M | $17.66M | $15.19M | $8.47M | $9.64M | $14.58M | $5.18M | $7.55M | $10.05M |
| High Forecast | $15.56M | $19.07M | $21.65M | $19.90M | $14.58M | $17.93M | $19.84M | $18.60M | $13.53M | $16.84M | $19.14M | $20.08M | $11.12M | $13.28M | $15.88M | $18.26M | $11.49M | $11.85M | $15.04M | $16.60M | $10.05M | $11.41M | $17.66M | $18.22M | $8.47M | $9.64M | $14.58M | $6.21M | $7.55M | $10.05M |
| Low Forecast | $15.56M | $19.07M | $21.65M | $19.90M | $14.58M | $17.93M | $19.84M | $18.60M | $13.53M | $16.76M | $19.14M | $13.39M | $10.86M | $13.28M | $15.88M | $12.17M | $7.66M | $11.85M | $15.04M | $11.07M | $10.05M | $11.41M | $17.66M | $12.15M | $8.47M | $9.64M | $14.58M | $4.14M | $7.55M | $10.05M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.00% | 0.70% | 0.00% | 1.80% | 0.17% | 1.14% | 1.35% | 1.33% | 0.59% | 0.62% | 1.11% | 1.27% | 0.89% | 0.73% | 0.72% | 1.33% | -0.57% | 0.35% |
5 analysts predict PETQ's average Quarter EBITDA for Dec 23 to be $10.96M, with a high of $11.12M and a low of $10.86M. This is 17.18% upper than PetIQ's previous annual EBITDA (Sep 23) of $9.36M.
PetIQ Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 9 | 15 | 9 | 9 | 16 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-17.49K | $451.00K | $9.47K | $9.70M | $-6.89M | $-49.57M | $4.63M | $3.13M | $-14.47M | $-7.90M | $4.03M | $2.03M | $-10.42M | $-63.06M | $-1.89M | $-2.10M | $-10.99M | $-5.89M |
| Avg Forecast | $5.96M | $20.38M | $26.44M | $24.84M | $6.99M | $15.72M | $19.92M | $25.86M | $1.75M | $17.12M | $17.63M | $2.86M | $-11.02M | $583.50K | $9.08M | $2.60M | $-13.18M | $2.03M | $11.74M | $2.36M | $628.92K | $3.14M | $25.62M | $1.60M | $-3.61M | $5.53M | $15.84M | $-1.58M | $1.92M | $12.37M |
| High Forecast | $5.96M | $20.38M | $26.44M | $24.84M | $6.99M | $15.72M | $19.92M | $25.86M | $1.75M | $17.12M | $17.64M | $3.43M | $-7.60M | $588.74K | $9.08M | $3.12M | $-10.54M | $2.03M | $11.74M | $2.83M | $628.92K | $3.14M | $25.62M | $1.92M | $-3.61M | $5.53M | $15.84M | $-1.26M | $1.92M | $12.37M |
| Low Forecast | $5.96M | $20.38M | $26.44M | $24.84M | $6.99M | $15.72M | $19.92M | $25.86M | $1.75M | $17.12M | $17.62M | $2.29M | $-15.58M | $578.26K | $9.08M | $2.08M | $-15.82M | $2.03M | $11.74M | $1.89M | $628.92K | $3.14M | $25.62M | $1.28M | $-3.61M | $5.53M | $15.84M | $-1.89M | $1.92M | $12.37M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 0.77% | 0.00% | 3.73% | 0.52% | -24.46% | 0.39% | 1.33% | -23.02% | -2.51% | 0.16% | 1.27% | 2.89% | -11.40% | -0.12% | 1.33% | -5.72% | -0.48% |
PetIQ's average Quarter net income forecast for Dec 23 is $-11.02M, with a range of $-15.58M to $-7.60M. PETQ's average Quarter net income forecast represents a -2543.48% decrease compared to the company's last Quarter net income of $451.00K (Sep 23).
PetIQ SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 9 | 15 | 9 | 9 | 16 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $42.73K | $55.02M | $55.16K | $43.33M | $37.75M | $45.98M | $50.59M | $48.24M | $41.45M | $45.25M | $43.14M | $40.67M | $32.63M | $35.56M | $38.49M | $31.69M | $28.87M | $29.34M |
| Avg Forecast | $47.12M | $57.73M | $65.53M | $60.23M | $44.14M | $54.28M | $60.05M | $56.31M | $40.97M | $50.85M | $57.95M | $44.02M | $33.18M | $40.21M | $48.06M | $40.02M | $41.28M | $35.87M | $45.54M | $36.38M | $30.43M | $34.55M | $53.47M | $31.96M | $25.64M | $29.19M | $44.15M | $23.77M | $22.87M | $30.42M |
| High Forecast | $47.12M | $57.73M | $65.53M | $60.23M | $44.14M | $54.28M | $60.05M | $56.31M | $40.97M | $50.97M | $57.95M | $52.82M | $33.67M | $40.21M | $48.06M | $48.02M | $49.53M | $35.87M | $45.54M | $43.66M | $30.43M | $34.55M | $53.47M | $38.35M | $25.64M | $29.19M | $44.15M | $28.52M | $22.87M | $30.42M |
| Low Forecast | $47.12M | $57.73M | $65.53M | $60.23M | $44.14M | $54.28M | $60.05M | $56.31M | $40.97M | $50.73M | $57.95M | $35.22M | $32.89M | $40.21M | $48.06M | $32.01M | $33.02M | $35.87M | $45.54M | $29.10M | $30.43M | $34.55M | $53.47M | $25.57M | $25.64M | $29.19M | $44.15M | $19.01M | $22.87M | $30.42M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.37% | 0.00% | 1.08% | 0.91% | 1.28% | 1.11% | 1.33% | 1.36% | 1.31% | 0.81% | 1.27% | 1.27% | 1.22% | 0.87% | 1.33% | 1.26% | 0.96% |
PetIQ's average Quarter SG&A projection for Mar 24 is $44.02M, based on 4 Wall Street analysts, with a range of $35.22M to $52.82M. The forecast indicates a 102920.93% rise compared to PETQ last annual SG&A of $42.73K (Dec 23).
PetIQ EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 9 | 15 | 9 | 9 | 16 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.60 | $0.02 | $0.32 | $0.33 | $-0.24 | $-1.70 | $0.16 | $0.11 | $-0.50 | $-0.27 | $0.14 | $0.08 | $-0.41 | $-2.53 | $-0.08 | $-0.09 | $-0.47 | $-0.26 |
| Avg Forecast | $0.17 | $0.58 | $0.76 | $0.71 | $0.20 | $0.45 | $0.57 | $0.74 | $0.05 | $0.49 | $0.50 | $0.43 | $-0.32 | $0.02 | $0.26 | $0.35 | $-0.09 | $0.06 | $0.34 | $0.37 | $0.02 | $0.09 | $0.73 | $0.14 | $-0.10 | $0.16 | $0.45 | $0.16 | $0.06 | $0.35 |
| High Forecast | $0.17 | $0.58 | $0.76 | $0.71 | $0.20 | $0.45 | $0.57 | $0.74 | $0.05 | $0.49 | $0.50 | $0.43 | $-0.22 | $0.02 | $0.26 | $0.35 | $-0.09 | $0.06 | $0.34 | $0.37 | $0.02 | $0.09 | $0.73 | $0.14 | $-0.10 | $0.16 | $0.45 | $0.16 | $0.06 | $0.35 |
| Low Forecast | $0.17 | $0.58 | $0.76 | $0.71 | $0.20 | $0.45 | $0.57 | $0.74 | $0.05 | $0.49 | $0.50 | $0.43 | $-0.45 | $0.02 | $0.26 | $0.35 | $-0.09 | $0.06 | $0.34 | $0.37 | $0.02 | $0.09 | $0.73 | $0.14 | $-0.10 | $0.16 | $0.45 | $0.16 | $0.06 | $0.35 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.90% | 0.93% | 1.23% | 0.95% | 2.55% | -29.31% | 0.48% | 0.30% | -27.78% | -3.00% | 0.19% | 0.56% | 3.97% | -15.98% | -0.18% | -0.56% | -8.55% | -0.73% |
According to 5 Wall Street analysts, PetIQ's projected average Quarter EPS for Dec 23 is $-0.32, with a low estimate of $-0.45 and a high estimate of $-0.22. This represents a -2134.84% decrease compared to PETQ previous annual EPS of $0.02 (Sep 23).
PetIQ Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions | $9.40 | $51.50 | 447.87% | Buy |
| PCRX | Pacira BioSciences | $17.38 | $35.00 | 101.38% | Hold |
| EVO | Evotec SE | $5.35 | $8.00 | 49.53% | Buy |
| ANIP | ANI Pharmaceuticals | $55.86 | $79.00 | 41.42% | Buy |
| COLL | Collegium Pharmaceutical | $30.41 | $40.50 | 33.18% | Buy |
| ZTS | Zoetis | $176.71 | $227.71 | 28.86% | Buy |
| BHC | Bausch Health Companies | $8.18 | $10.00 | 22.25% | Hold |
| NBIX | Neurocrine Biosciences | $125.00 | $147.35 | 17.88% | Buy |
| PBH | Prestige Consumer Healthcare | $84.14 | $89.50 | 6.37% | Buy |
| SUPN | Supernus Pharmaceuticals | $35.82 | $38.00 | 6.09% | Buy |
| DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
| PETQ | PetIQ | $30.98 | $31.00 | 0.06% | Buy |
| PAHC | Phibro Animal Health | $23.76 | $18.67 | -21.42% | Buy |